Literature DB >> 6186758

Short-term inhibition of duodenal tryptic activity does not affect human pancreatic, biliary, or gastric function.

J Hotz, S B Ho, V L Go, E P DiMagno.   

Abstract

Existence of feedback inhibition of pancreatic secretion by luminal pancreatic trypsin in humans is controversial. We examined the effect of duodenal tryptic activity on pancreatic, biliary, and gastric functions. In six healthy volunteers, gastric acid secretion and emptying and the secretion of pancreatic enzymes, bicarbonate, and bile acids into the duodenum were measured for 7 hr with a double-marker perfusion technique. Each experiment consisted of six test periods. The effects of the addition of active and inactive aprotinin to duodenal saline perfusion were determined during fasting and after administration of a saline test meal. We found that (1) aprotinin eliminated tryptic activity in the preprandial state and reduced it by more than 95% during meal periods; (2) compared to inactivated aprotinin, no differences in the outputs of bicarbonate, amylase, lipase, chymotrypsin, and bile acids occurred during preprandial or postprandial aprotinin periods; and (3) gastric acid secretion, emptying, and duodenogastric reflux were similar during aprotinin and inactivated-aprotinin perfusions. We conclude that short-term, almost complete reduction of intraduodenal tryptic activity does not alter exocrine pancreatic secretion or gastric function in the unstimulated state or in response to a moderate stimulation by a saline test meal. Therefore the importance of negative feedback control of pancreatic secretion by acute alteration of intraduodenal tryptic activity must be questioned in healthy humans.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6186758

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


  12 in total

Review 1.  Pancreatic enzyme replacement therapy.

Authors:  P Layer; J Keller; P G Lankisch
Journal:  Curr Gastroenterol Rep       Date:  2001-04

Review 2.  Is there a duodenum-pancreas negative feedback? Views: pro and con.

Authors:  D F Magee
Journal:  Int J Pancreatol       Date:  1991-05

Review 3.  Management of pain in chronic pancreatitis with emphasis on exogenous pancreatic enzymes.

Authors:  Paul M Hobbs; William G Johnson; David Y Graham
Journal:  World J Gastrointest Pharmacol Ther       Date:  2016-08-06

4.  Time-course of the pancreatic changes following long-term stimulation or inhibition of the CCK-A receptor.

Authors:  B Ohlsson; J Axelson; B Sternby; J F Rehfeld; I Ihse
Journal:  Int J Pancreatol       Date:  1995-08

5.  Influence of high-dose pancreatic enzyme treatment on pancreatic function in healthy volunteers.

Authors:  H Friess; J Kleeff; P Malfertheiner; M W Müller; K Homuth; M W Büchler
Journal:  Int J Pancreatol       Date:  1998-04

Review 6.  Pancreatic enzymes in chronic pancreatitis.

Authors:  P Layer; G Holtmann
Journal:  Int J Pancreatol       Date:  1994-02

Review 7.  Perspectives of CCK antagonists in pancreatic research. Part II. Experimental studies.

Authors:  T Takács; A Pap
Journal:  Int J Pancreatol       Date:  1991-09

8.  Gastrin-releasing peptide and CCK after intraduodenal inhibition of proteases in dogs.

Authors:  R Nustede; W E Schmidt; M Jäger; F Stöckmann; H Köhler; U R Fölsch; H J Peiper
Journal:  Int J Pancreatol       Date:  1994-06

9.  Changes in plasma and duodenal cholecystokinin concentrations after pancreatic duct occlusion in rats.

Authors:  K Miyasaka; A Funakoshi; A Jimi; R Nakamura; M Matsumoto; K Kitani
Journal:  Dig Dis Sci       Date:  1992-03       Impact factor: 3.199

10.  Influence of treatment with pancreatic extracts on pancreatic enzyme secretion.

Authors:  J Mössner; H P Wresky; W Kestel; J Zeeh; U Regner; W Fischbach
Journal:  Gut       Date:  1989-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.